A
Amelia Rios
Researcher at CINVESTAV
Publications - 43
Citations - 724
Amelia Rios is an academic researcher from CINVESTAV. The author has contributed to research in topics: Nitric oxide & Enos. The author has an hindex of 15, co-authored 38 publications receiving 636 citations. Previous affiliations of Amelia Rios include Instituto Politécnico Nacional.
Papers
More filters
Journal ArticleDOI
The role of nitric oxide in the post-ischemic revascularization process.
Diana Luque Contreras,Hilda Vargas Robles,Eunice Romo,Amelia Rios,Bruno Escalante,Bruno Escalante +5 more
TL;DR: Impairment of the NO metabolic pathway could be one of the main contributing factors for the development of peripheral arterial occlusive disease and the restoration of normal NO levels in diseased arteries is a major therapeutic goal.
Journal Article
Effect of phlorizin on SGLT2 expression in the kidney of diabetic rats.
Horacio Osorio,Rocio Bautista,Amelia Rios,Martha Franco,Abraham Arellano,Hilda Vargas-Robles,Eunice Romo,Bruno Escalante,Bruno Escalante +8 more
TL;DR: SGLT2 inhibition prevented the development of hypertension in diabetic rats as well as hyperglycemia, suggesting a hypertensive mechanism associated with S GLT2 activity and the likelihood that increased SGLT 2 expression may be associated with progression of diabetic renal complications.
Journal ArticleDOI
Effect of treatment with losartan on salt sensitivity and SGLT2 expression in hypertensive diabetic rats.
Horacio Osorio,Rocio Bautista,Amelia Rios,Martha Franco,José Santamaría,Bruno Escalante,Bruno Escalante +6 more
TL;DR: Losartan prevented an increase in BP and SGLT2 expression in diabetic rats and the effect of losartan on blood pressure was evaluated in diabetic Rats with high or normal salt diet.
Journal ArticleDOI
An Affordable and Portable Thermocycler for Real-Time PCR Made of 3D-Printed Parts and Off-the-Shelf Electronics.
TL;DR: A low-cost, palm-size, and portable instrument to perform real-time PCR (qPCR), achieving similar limits of detection as those achieved by a benchtop thermocycler and being utilized to enable routine monitoring and diagnosis of certain diseases in low-resource areas.
Journal ArticleDOI
Cyclooxygenase-2 and kidney failure.
TL;DR: Although, specific COX-2 pharmacological inhibition has been related to the prevention of kidney damage, clinical studies have reported that COx-2 inhibition may cause side effects such as edema or a modest elevation in blood pressure and could possibly interfere with antihypertensive drugs and increase the risk of cardiovascular complications.